Chronic wounds represent a drain on the Spanish health system, nowdays is necessary an optimization of the resources used and that is for this that is necessary justify the use of the products over others through cost-effective studies for to show the economic benefit to professionals and the life quality of patient. This article compares the use of a new technology for format polyurethane foam, TLC-NOSF, with the most commonly used products for treating wounds. This comparison is made using a cost-effectiveness model (Markov Model).
View Article and Find Full Text PDFRev Enferm
October 2012
The treatment of chronic wounds requires the use of highly specific products for different phases of the healing process. This article raises a number of clinical cases with chronic wounds of vascular origin and pressure ulcers. Such cases required a initial debridement because of the large content of fibrin covering the wound bed at this stage was used dressing hidrodetersive polyacrylate fibers with TLC.
View Article and Find Full Text PDFDupuytren disease starts with a fracture in the hand which in most cases requires surgery. In the Galdakao Hospital during 2006 and early 2007, medical personnel carried out a study to evaluate the effectiveness of a Aquacel wet cure dressing (Hydrofiber Technology, ConvaTec, Bristol-Myers Squibb) in treatment for secondary wounds after surgery to deal with Dupuytren pathology. 52 patients who underwent surgery for Dupuytren pathology were included in this study, in stages from N to IV, using surgical techniques Skoog and Skoog and McCash.
View Article and Find Full Text PDF